Early lab work on a protein that may help brain tumors grow
Original title: METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is early lab work in cells, and it has not been tested in people.
The short version
Scientists are studying a protein that seems to help cancers grow, and they have made a first lab drug to block it.
What was studied. This is a review paper. Experts went back over lab studies of a protein called METTL1 and its partner protein WDR4. They also looked at new drugs made in the lab to block METTL1.
What they found. METTL1 and WDR4 change how cells read and use their genetic instructions. In many cancers, including glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, which is a brain tumor, these proteins appear to help the cancer grow, repair itself, and hide from the immune system. New drugs made in the lab were able to block METTL1 inside cells and turn down its activity.
What this means, and what it doesn't
What it could mean: This does not change care today. It points to a possible new target that future brain tumor drugs might aim at. Any drug that comes from this work would need years of testing first.
What it doesn't mean: This is early lab work only. The drugs were tested in cells in a dish, not in people. Nothing here is available to patients, and there is no proof it helps anyone live longer or feel better. It is not a cure and it is not a promise of one. METTL1 also does normal jobs in the heart, blood vessels, and nervous system, so blocking it may turn out to be hard to do safely.
Source: PubMed, July 20, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.